InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088
$35.44 +3.60% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $35.44 +417.37% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 1 Oct 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue23.8Operating income−1,070.9Net income−809.2Fiscal year 2022Revenue55.3 +132.3%Operating income−1,351.6Net income−845.3EPS, diluted−1.26Fiscal year 2023Revenue31.5 −43.0%Operating income−906.8Net income−1,009.0EPS, diluted−1.42Fiscal year 2024Revenue32.7 +3.8%Operating income4,497.0Net income4,348.9EPS, diluted5.23Fiscal year 2025Revenue29.1 −11.2%Operating income−1,003.3Net income−172.0 −104.0%EPS, diluted−0.24 −104.6%Fiscal year 2026Revenue8.3 −71.6%Operating income−515.1Net income−299.8EPS, diluted−0.54
FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 23.8 55.3 31.5 32.7 29.1 8.3
Growth +132.3% −43.0% +3.8% −11.2% −71.6%
Operating income −1,070.9 −1,351.6 −906.8 4,497.0 −1,003.3 −515.1
Net income −809.2 −845.3 −1,009.0 4,348.9 −172.0 −299.8
Growth −104.0%
EPS, diluted n/a −1.26 −1.42 5.23 −0.24 −0.54
Growth −104.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin−4,500.5%Net margin−3,400.9%Free cash flow margin−2,344.8%Fiscal year 2022Operating margin−2,444.8%Net margin−1,528.9%Free cash flow margin−1,257.4%Fiscal year 2023Operating margin−2,875.9%Net margin−3,200.2%Free cash flow margin−2,715.1%Fiscal year 2024Operating margin13,746.9%Net margin13,294.2%Free cash flow margin−2,343.6%Fiscal year 2025Operating margin−3,453.3%Net margin−592.0%Free cash flow margin−2,905.2%Fiscal year 2026Operating margin−6,235.7%Net margin−3,629.2%Free cash flow margin−9,183.5%
FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin −4,500.5% −2,444.8% −2,875.9% 13,746.9% −3,453.3% −6,235.7%
Net margin −3,400.9% −1,528.9% −3,200.2% 13,294.2% −592.0% −3,629.2%
Free cash flow margin −2,344.8% −1,257.4% −2,715.1% −2,343.6% −2,905.2% −9,183.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−552.1Capital expenditure−5.8Free cash flow−557.9Fiscal year 2022Operating cash flow−677.7Capital expenditure−17.4Free cash flow−695.2Fiscal year 2023Operating cash flow−843.4Capital expenditure−12.7Free cash flow−856.1Buybacks0.0Fiscal year 2024Operating cash flow−765.3Capital expenditure−1.4Free cash flow−766.7Buybacks0.0Fiscal year 2025Operating cash flow−839.5Capital expenditure−4.6Free cash flow−844.1Buybacks−1,293.2Fiscal year 2026Operating cash flow−750.3Capital expenditure−8.2Free cash flow−758.6
FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −552.1 −677.7 −843.4 −765.3 −839.5 −750.3
Capital expenditure −5.8 −17.4 −12.7 −1.4 −4.6 −8.2
Free cash flow −557.9 −695.2 −856.1 −766.7 −844.1 −758.6
Growth
Buybacks n/a n/a 0.0 0.0 −1,293.2 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash2,055.0Total debt170.3Net cash (debt)1,884.8Shareholders’ equity1,797.8Debt to equity0.09Fiscal year 2022Cash2,060.4Total debt210.0Net cash (debt)1,850.4Shareholders’ equity1,656.9Debt to equity0.13Fiscal year 2023Cash1,676.8Total debt416.2Net cash (debt)1,260.6Shareholders’ equity1,157.8Debt to equity0.36Fiscal year 2024Cash6,495.0Total debt442.6Net cash (debt)6,052.4Shareholders’ equity5,968.6Debt to equity0.07Fiscal year 2025Cash2,715.4Shareholders’ equity4,687.6Fiscal year 2026Cash1,419.2Shareholders’ equity4,527.4
FY2021FY2022FY2023FY2024FY2025FY2026
Cash 2,055.0 2,060.4 1,676.8 6,495.0 2,715.4 1,419.2
Total debt 170.3 210.0 416.2 442.6 n/a n/a
Net cash (debt) 1,884.8 1,850.4 1,260.6 6,052.4 n/a n/a
Shareholders’ equity 1,797.8 1,656.9 1,157.8 5,968.6 4,687.6 4,527.4
Debt to equity 0.09 0.13 0.36 0.07 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025 31 Mar 2025 FY2026 31 Mar 2026
Operations
−552.1 −677.7 −843.4 −765.3 −839.5 −750.3
Growth
n/a 5.9 18.9 22.0 14.1 3.3
Investment
−5.8 −17.4 −12.7 −1.4 −4.6 −8.2
calc −557.9 −695.2 −856.1 −766.7 −844.1 −758.6
Growth
calc n/a −1.04 −1.20 −0.92 −1.16 −1.09
−31.7 303.3 −44.3 5,203.6 −1,766.3 −682.3
Financing
456.3 306.8 499.5 419.4 −1,219.8 134.2
n/a n/a 0.0 0.0 −1,293.2 n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.